These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 33385734)
1. Gene co-expression modules integrated with immunoscore predicts survival of non-small cell lung cancer. Li XT; Zhang JT; Yan HH; Su J; Cheng ML; Sun QH; Zhong WZ; Wu YL; Zhang DX; Hou DJ Cancer Treat Res Commun; 2021; 26():100297. PubMed ID: 33385734 [TBL] [Abstract][Full Text] [Related]
2. APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC. Li Y; Zhao X; Xiao H; Yang B; Liu J; Rao W; Dai X; Li M; Dai N; Yang Y; Wang D BMC Cancer; 2021 Mar; 21(1):233. PubMed ID: 33676448 [TBL] [Abstract][Full Text] [Related]
3. Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy. Li C; Pan J; Luo J; Chen X BMC Pulm Med; 2021 Nov; 21(1):389. PubMed ID: 34844602 [TBL] [Abstract][Full Text] [Related]
4. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma. Chen QF; Li W; Wu PH; Shen LJ; Huang ZL World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model. Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229 [TBL] [Abstract][Full Text] [Related]
6. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma. Xu F; Zhang H; Chen J; Lin L; Chen Y Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430 [TBL] [Abstract][Full Text] [Related]
7. Identification and Prognostic Value Exploration of Radiotherapy Sensitivity-Associated Genes in Non-Small-Cell Lung Cancer. Ma Q; Geng K; Xiao P; Zeng L Biomed Res Int; 2021; 2021():5963868. PubMed ID: 34518802 [TBL] [Abstract][Full Text] [Related]
8. A comprehensive meta-analysis of tissue resident memory T cells and their roles in shaping immune microenvironment and patient prognosis in non-small cell lung cancer. Shen A; Garrett A; Chao CC; Liu D; Cheng C; Wang Z; Qian C; Zhu Y; Mai J; Jiang C Front Immunol; 2024; 15():1416751. PubMed ID: 39040095 [TBL] [Abstract][Full Text] [Related]
9. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer]. Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273 [TBL] [Abstract][Full Text] [Related]
10. Real-world comprehensive genomic and immune profiling reveals distinct age- and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer. Wallen ZD; Ko H; Nesline MK; Hastings SB; Strickland KC; Previs RA; Zhang S; Pabla S; Conroy J; Jackson JB; Saini KS; Jensen TJ; Eisenberg M; Caveney B; Sathyan P; Severson EA; Ramkissoon SH Front Immunol; 2024; 15():1413956. PubMed ID: 38975340 [TBL] [Abstract][Full Text] [Related]
11. Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values. Wang T; Chen X; Jing F; Li Z; Tan H; Luo Y; Shi H Pathol Res Pract; 2021 Dec; 228():153654. PubMed ID: 34749208 [TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer. Chen J; Wu R; Xuan Y; Jiang M; Zeng Y Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465 [TBL] [Abstract][Full Text] [Related]
13. Immune Infiltration Profiling in Nonsmall Cell Lung Cancer and Their Clinical Significance: Study Based on Gene Expression Measurements. Chen F; Yang Y; Zhao Y; Pei L; Yan H DNA Cell Biol; 2019 Nov; 38(11):1387-1401. PubMed ID: 31549881 [TBL] [Abstract][Full Text] [Related]
14. Revealing prognostic insights of programmed cell death (PCD)-associated genes in advanced non-small cell lung cancer. Dong W; Zhang H; Han L; Zhao H; Zhang Y; Liu S; Zhang J; Niu B; Xiao W Aging (Albany NY); 2024 May; 16(9):8110-8141. PubMed ID: 38728242 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers. Usó M; Jantus-Lewintre E; Bremnes RM; Calabuig S; Blasco A; Pastor E; Borreda I; Molina-Pinelo S; Paz-Ares L; Guijarro R; Martorell M; Forteza J; Camps C; Sirera R Oncotarget; 2016 Aug; 7(33):52849-52861. PubMed ID: 27463005 [TBL] [Abstract][Full Text] [Related]
16. LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival. Hald SM; Rakaee M; Martinez I; Richardsen E; Al-Saad S; Paulsen EE; Blix ES; Kilvaer T; Andersen S; Busund LT; Bremnes RM; Donnem T Clin Lung Cancer; 2018 May; 19(3):249-259.e2. PubMed ID: 29396238 [TBL] [Abstract][Full Text] [Related]
17. High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLC. Oh MS; Anker JF; Chae YK Cancer Treat Res Commun; 2021; 27():100317. PubMed ID: 33711637 [TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer. Zhang X; Shi X; Zhao H; Jia X; Yang Y Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055 [TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer. Zhou M; Chen Y; Gu X; Wang C Pathol Oncol Res; 2022; 28():1610504. PubMed ID: 36061144 [No Abstract] [Full Text] [Related]